Cargando…

A qualitative transcriptional signature to reclassify histological grade of ER-positive breast cancer patients

BACKGROUND: Histological grade (HG) is commonly adopted as a prognostic factor for ER-positive breast cancer patients. However, HG evaluation methods, such as the pathological Nottingham grading system, are highly subjective with only 50–85% inter-observer agreements. Specifically, the subjectivity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jing, Jiang, Wenbin, Liang, Qirui, Liu, Guanghao, Dai, Yupeng, Zheng, Hailong, Yang, Jing, Cai, Hao, Zheng, Guo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132979/ https://www.ncbi.nlm.nih.gov/pubmed/32252627 http://dx.doi.org/10.1186/s12864-020-6659-0

Ejemplares similares

Reclassifying stroke lesion anatomy
por: Bonkhoff, Anna K., et al.
Publicado: (2021)

A qualitative transcriptional signature for the histological reclassification of lung squamous cell carcinomas and adenocarcinomas
por: Li, Xin, et al.
Publicado: (2019)

Reclassifying Pseudopolyps in Inflammatory Bowel Disease: Histologic and Endoscopic Description in the New Era of Mucosal Healing
por: Rezapour, Mona, et al.
Publicado: (2019)

Codeine-containing medicines to be reclassified in NZ
Publicado: (2020)

A Qualitative Transcriptional Signature for Predicting Extreme Resistance of ER-Negative Breast Cancer to Paclitaxel, Doxorubicin, and Cyclophosphamide Neoadjuvant Chemotherapy
por: Chen, Yanhua, et al.
Publicado: (2020)

Reclassifying tumour cell cycle activity in terms of its tissue of origin
por: Lundberg, Arian, et al.
Publicado: (2022)

A Five-Gene-Pair-Based Prognostic Signature for Predicting the Relapse Risk of Early Stage ER+ Breast Cancer
por: Li, Na, et al.
Publicado: (2020)

Reclassifying ovarian cancer: origins, subtypes and resistance to therapy
por: Bowtell, DDL
Publicado: (2012)

Need to reclassify keratocystic odontogenic tumor into cyst and neoplasm
por: Singh, Harkanwal Preet
Publicado: (2016)

How genomics reclassifies diseases: the case of Alport syndrome
por: Torra, Roser, et al.
Publicado: (2020)

Reclassifying contraceptives as over-the-counter medicines to improve access
por: Ammerdorffer, Anne, et al.
Publicado: (2022)

Malignant pheochromocytoma with negative biochemical markers: Is it time to reclassify pheochromocytomas?
por: Borzouei, Shiva, et al.
Publicado: (2019)

Commentary: Descending necrotizing mediastinitis: Reclassifying a rare disease
por: Bajpai, Swara, et al.
Publicado: (2021)

Update on rare variants in inherited arrhythmogenic syndromes: when to reclassify?
por: Martinez Barrios, E, et al.
Publicado: (2023)

Are We Ready to Reclassify Crohn’s Disease Using Molecular Classification?
por: Kamal, Shahed, et al.
Publicado: (2023)

A robust qualitative transcriptional signature for the correct pathological diagnosis of gastric cancer
por: Yan, Haidan, et al.
Publicado: (2019)

A Qualitative Transcriptional Signature for Predicting CpG Island Methylator Phenotype Status of the Right-Sided Colon Cancer
por: You, Tianyi, et al.
Publicado: (2020)

A method for reclassifying cause of death in cases categorized as “event of undetermined intent”
por: Andreev, Evgeny, et al.
Publicado: (2015)

Reclassifying causes of obstetric death in Mexico: a repeated cross-sectional study
por: Hogan, Margaret C, et al.
Publicado: (2016)

Combination genetic signature stratifies lower-grade gliomas better than histological grade
por: Chan, Aden Ka-Yin, et al.
Publicado: (2015)

Auto-immune skin diseases in animals: time to reclassify and review after 40 years
por: Olivry, Thierry
Publicado: (2018)

The Identification of Metal Ion Ligand-Binding Residues by Adding the Reclassified Relative Solvent Accessibility
por: Hu, Xiuzhen, et al.
Publicado: (2020)

Tumor tissue protein signatures reflect histological grade of breast cancer
por: Skoog, Petter, et al.
Publicado: (2017)

An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer
por: Zhou, Xin, et al.
Publicado: (2014)

Obesity measures in the Kiribati population: a need to reclassify body mass index cut-points
por: Eme, P. E., et al.
Publicado: (2020)

Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting Therapy
por: Shen, Shuai, et al.
Publicado: (2020)

Carotid Plaque Assessment Reclassifies Patients with Inflammatory Bowel Disease into Very-High Cardiovascular Risk
por: Hernández-Camba, Alejandro, et al.
Publicado: (2021)

Reclassifying variations of unknown significance in diseases affecting Saudi Arabia’s population reveal new associations
por: Al Eissa, Mariam M., et al.
Publicado: (2023)

Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer
por: Cai, Hao, et al.
Publicado: (2015)

Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer
por: Guan, Qingzhou, et al.
Publicado: (2018)

Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature
por: Whitworth, Pat W., et al.
Publicado: (2022)

Reclassifying severity after 48 hours could better predict mortality in acute respiratory distress syndrome
por: Chiu, Li-Chung, et al.
Publicado: (2020)

A Qualitative Transcriptional Signature for Predicting Recurrence Risk for High-Grade Serous Ovarian Cancer Patients Treated With Platinum-Taxane Adjuvant Chemotherapy
por: Liu, Yixin, et al.
Publicado: (2019)

Image analysis with deep learning to predict breast cancer grade, ER status, histologic subtype, and intrinsic subtype
por: Couture, Heather D., et al.
Publicado: (2018)

A qualitative transcriptional signature for the early diagnosis of colorectal cancer
por: Guan, Qingzhou, et al.
Publicado: (2019)

Reclassifying the spectrum of septic patients using lactate: severe sepsis, cryptic shock, vasoplegic shock and dysoxic shock
por: Ranzani, Otavio Tavares, et al.
Publicado: (2013)

Treating Clostridium difficile infections: Should fecal microbiota transplantation be reclassified from investigational drug to human tissue?()
por: Stuntz, Mark, et al.
Publicado: (2015)

2017 Global Initiative for Chronic Obstructive Lung Disease reclassifies half of COPD subjects to lower risk group
por: Högman, Marieann, et al.
Publicado: (2018)

Nine per cent of biopsy‐proven lentigo maligna lesions are reclassified as lentigo maligna melanoma after surgery
por: Zoutendijk, J., et al.
Publicado: (2019)

Taxogenomics Resolves Conflict in the Genus Rhodobacter: A Two and Half Decades Pending Thought to Reclassify the Genus Rhodobacter
por: Suresh, G., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0n2ano1pa2hsf1duo7p2emgbpk